
HIV prevention




Special Webinar (Archived Recording) – HIV and COVID-19 – When Pandemics Collide
RECORDED: Thursday, December 2, 2021, 12:00 – 1:30 p.m. ET ACCESS THE RECORDING Against the backdrop of the continuing COVID-19 pandemic, ICAP and the Columbia Mailman School Public Health commemorated World AIDS Day 2021 with an event that considered the status of...

September 2021: HPTN 083 Trial Results – Comparing Efficacy of Cabotegravir to Daily Oral TDF/FTC for PrEP in Cisgender Men and Transgender Women
Article and Study Summary: Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. Published in: N Engl J Med 2021;385(7):595-608. https://www.nejm.org/doi/full/10.1056/NEJMoa2101016 Authors: Landovitz RJ, Donnell D, Clement ME, et al. Summary: The HIV...

HIV incidence by male circumcision status from the population-based HIV impact assessment (PHIA) surveys-eight sub-Saharan African countries, 2015-2017
Hines JZ, Sachathep K, Pals S, Davis SM, Toledo C, Bronson M, Parekh B, Carrasco M, Xaba S, Mandisarisa J, Kamobyi R, Chituwo O, Kirungi WL, Alamo S, Kabuye G, Awor AC, Mmbando S, Simbeye D, Aupokolo MA, Zemburuka B, Nyirenda R, Msungama W, Tarumbiswa T, Manda R,...
